Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 15;3:222.
doi: 10.12688/f1000research.5218.1. eCollection 2014.

A Review of Creatine Supplementation in Age-Related Diseases: More Than a Supplement for Athletes

Free PMC article

A Review of Creatine Supplementation in Age-Related Diseases: More Than a Supplement for Athletes

Rachel N Smith et al. F1000Res. .
Free PMC article


Creatine is an endogenous compound synthesized from arginine, glycine and methionine. This dietary supplement can be acquired from food sources such as meat and fish, along with athlete supplement powders. Since the majority of creatine is stored in skeletal muscle, dietary creatine supplementation has traditionally been important for athletes and bodybuilders to increase the power, strength, and mass of the skeletal muscle. However, new uses for creatine have emerged suggesting that it may be important in preventing or delaying the onset of neurodegenerative diseases associated with aging. On average, 30% of muscle mass is lost by age 80, while muscular weakness remains a vital cause for loss of independence in the elderly population. In light of these new roles of creatine, the dietary supplement's usage has been studied to determine its efficacy in treating congestive heart failure, gyrate atrophy, insulin insensitivity, cancer, and high cholesterol. In relation to the brain, creatine has been shown to have antioxidant properties, reduce mental fatigue, protect the brain from neurotoxicity, and improve facets/components of neurological disorders like depression and bipolar disorder. The combination of these benefits has made creatine a leading candidate in the fight against age-related diseases, such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, long-term memory impairments associated with the progression of Alzheimer's disease, and stroke. In this review, we explore the normal mechanisms by which creatine is produced and its necessary physiology, while paying special attention to the importance of creatine supplementation in improving diseases and disorders associated with brain aging and outlining the clinical trials involving creatine to treat these diseases.

Keywords: Creatine; age-related diseases; central nervous system.

Conflict of interest statement

Competing interests: No competing interests were disclosed.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles


    1. Zeisel SH: Regulation of “nutraceuticals”. Science. 1999;285(5435):1853–1855. 10.1126/science.285.5435.1853 - DOI - PubMed
    1. Schnirring L: Creatine supplements face scrutiny: Will users pay later? Phys Sports Med. 1998;26:15–23.
    1. Bloch K, Schoenheimer R: The Biological Precursors Of Creatine. J Biol Chem. 1941;138(1):167–194 Reference Source
    1. Tarnopolsky MA, Beal MF: Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol. 2001;49(5):561–574. 10.1002/ana.1028 - DOI - PubMed
    1. Adhihetty PJ, Beal MF: Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular Med. 2008;10(4):275–290. 10.1007/s12017-008-8053-y - DOI - PMC - PubMed

Grant support

Rachel N. Smith is supported by a fellowship on an NIH National Institute on Aging Training Grant (T32AG020494). Eric B. Gonzales is supported by an American Heart Association Beginning Grant-in-Aid (12BGIA8820001) and an UNTHSC Institute for Aging and Alzheimer’s Disease Research (IAADR) Pilot Seed Grant.

LinkOut - more resources